United Therapeutics Corp (NASDAQ:UTHR)

181.85
Delayed Data
As of 4:14pm ET
 -1.61 / -0.88%
Today’s Change
84.63
Today|||52-Week Range
190.29
+40.44%
Year-to-Date

Stock Price Forecast

The 14 analysts offering 12-month price forecasts for United Therapeutics Corp have a median target of 170.50, with a high estimate of 225.00 and a low estimate of 98.00. The median estimate represents a -6.24% decrease from the last price of 181.85.

Analyst Recommendations

The current consensus among 15 polled investment analysts is to Buy stock in United Therapeutics Corp. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$2.32
Sales
$365.0M
Reporting Date
Jul 23

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 743.30%
 
 
 
 
 
 
Growthannually 17.06%
 
 
 
 
 
 

Sales

Growthquarterly 11.44%
 
 
 
 
 
 
Growthannually 15.93%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account